Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep-disordered breathing: a meta-analysis

Nakamura, Shun‐ichi; Asai, Kuniya; Kubota, Yoshiaki; Murai, Koji; Takano, Hitoshi; Tsukada, Yayoi; Shimizu, Wataru

doi:10.1007/s00392-014-0774-3

Cited by 56 publications

(20 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Reviewing sleep history (including asking a partner) is part of the holistic care of patients with HF (see Section 14). CSA and OSA have been shown to be associated with a worse prognosis in HF . OSA is associated with an increased risk of incident HF in men .…”

Section: Co‐morbiditiesmentioning

confidence: 99%

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Ponikowski¹,

Voors²,

Anker³

et al. 2016

European J of Heart Fail

5,229

2,284

View full text Add to dashboard Cite

Section: Co‐morbiditiesmentioning

confidence: 99%

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Ponikowski¹,

Voors²,

Anker³

et al. 2016

European J of Heart Fail

5,229

2,284

View full text Add to dashboard Cite

“…CSA and OSA have been shown to be associated with a worse prognosis in HF. 485,486 OSA is associated with an increased risk of incident HF in men. 487 CSA is the most common form of SDB in HFrEF, and HFrEF is the most common cause of CSA, so they are closely linked.…”

Section: Sleep Disturbance and Sleep-disordered Breathingmentioning

confidence: 99%

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

McMurray¹,

Adamopoulos²,

Anker³

et al. 2013

Revista Portuguesa de Cardiologia (English Edition)

214

315

View full text Add to dashboard Cite

“…Previous studies have reported that chronic ASV therapy improves sleep quality compared with other PAP devices in CHF patients with CSR , whereas Pepperell et al . studied the effect of ASV on daytime sleepiness and fail to observe improvement in ESS.…”

Section: Discussionmentioning

confidence: 91%

Adaptive servoventilation improves cardiac dysfunction and prognosis in heart failure patients with sleep‐disordered breathing: a meta‐analysis

Zhang

et al. 2015

Clinical Respiratory J

View full text Add to dashboard Cite

Authorship and contributorship SQL and LYJ contributed equally to this work and wrote the paper. XW designed research and analyzed data. CPF and SQZ contributed analytic tools. All authors have read and approved the final version. EthicsThis is a meta-analysis and not a clinical research involving human participants. Conflict of interestThe authors have stated explicitly that there are no conflicts of interest in connection with this article. AbstractBackground: Adaptive servoventilation (ASV) is a new therapeutic modality to treat sleep-disordered breathing (SDB) especially for central sleep apnoea associated with Cheyne-Stokes respiration, whereas the role of ASV in SDB patients with heart failure (HF) is controversial. The purpose of this study was to evaluate the effects of ASV on these patients through a meta-analysis of published data. Methods: A comprehensive literature search was performed to identify studies focused on ASV through databases, including PubMed, Medline, Embase, Cochrane Library and Web of science from 1950 to 2014. Parallel randomised controlled trials which compared ASV to other controls in HF and SDB patients with extractable data were meet our inclusion criteria. Random effects meta-analysis models were applied using RevMan 5.2. Results: Seven studies involving 301 patients were recruited in the meta-analysis. The weighted mean difference in apnoea hyponea index (217.73 events/h, 95% CI, 221.85 to 22.94) and left ventricular ejection fraction (MD: 4.68, 95% CI, 2.74-6.63) both favored ASV compared to control conditions. The urinary noradrenaline level (MD: 232.18, 95%CI: 244.07 to 220.09) was decreased, while the exercise capacity measured by 6-min walk distance (MD: 41.26, 95% CI, 17.06-65.45) was improved after ASV treatment. Whereas neither left ventricular end-diastolic diameter (LVEDD) nor Epworth sleepiness-scale score (ESS) significantly changed after ASV therapy. Conclusions: ASV is superior to other therapy, as it can result in good consequences for patients with SDB and improve their prognosis in cardiac function. Further studies will still be needed to assess the benefit of it.Please cite this paper as: Wu X, Fu C, Zhang S, Liu Z, Li S and Jiang L. Adaptive servoventilation improves cardiac dysfunction and prognosis in heart failure patients with sleep-disordered breathing: a meta-analysis.

show abstract

Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep-disordered breathing: a meta-analysis

Abstract: The prevalence of SDB in patients with chronic HF is associated with worse survival, and ASV reduces all-cause mortality in patients with chronic HF concomitant with SDB.

Cited by 56 publications

References 37 publications

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

Adaptive servoventilation improves cardiac dysfunction and prognosis in heart failure patients with sleep‐disordered breathing: a meta‐analysis

Contact Info

Product

Resources

About